DGAP-News: Raptor Pharmaceutical Licenses Intellectual Property Related to Malaria From McGill University
Raptor Pharmaceutical Corp.
29.05.2012 13:30
—————————————————————————
NOVATO, Calif., 2012-05-29 13:30 CEST (GLOBE NEWSWIRE) —
Raptor Pharmaceutical Corp. (–Raptor– or the –Company–) (Nasdaq:RPTP),
announced that the Company has acquired exclusive rights to intellectual
property related to cysteamine and related compounds in the potential treatment
of parasitic diseases, including malaria, from McGill University (–McGill–) in
Montreal,
